MENU
+Compare
BNXTF
Stock ticker: OTC
AS OF
Oct 9 closing price
Price
$0.62
Change
-$0.00 (-0.00%)
Capitalization
50.15M

BNXTF BIONXT SOLUTIONS INC. Forecast, Technical & Fundamental Analysis

BioNxt Solutions Inc is a cannabis company focused on next-generation drug formulations and delivery systems... Show more

BNXTF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for BNXTF with price predictions
Feb 03, 2026

BNXTF's Stochastic Oscillator is staying in overbought zone for 4 days

The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 50-day moving average for BNXTF moved below the 200-day moving average on January 12, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BNXTF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BNXTF broke above its upper Bollinger Band on January 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for BNXTF entered a downward trend on January 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BNXTF's RSI Indicator exited the oversold zone, of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on January 27, 2026. You may want to consider a long position or call options on BNXTF as a result. In of 114 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BNXTF just turned positive on January 27, 2026. Looking at past instances where BNXTF's MACD turned positive, the stock continued to rise in of 65 cases over the following month. The odds of a continued upward trend are .

BNXTF moved above its 50-day moving average on January 27, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +3 3-day Advance, the price is estimated to grow further. Considering data from situations where BNXTF advanced for three days, in of 128 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BNXTF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (29.792). P/E Ratio (0.000) is within average values for comparable stocks, (74.095). BNXTF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.035). BNXTF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.029). BNXTF's P/S Ratio (5000.000) is very high in comparison to the industry average of (116.680).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BNXTF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
BNXTF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
1820 Fir Street
Phone
+1 780 818-6422
Employees
6
Web
https://www.bionxt.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMMX0.14N/A
N/A
AmeraMex International Inc.
CZNL51.99N/A
N/A
Citizens National Corp.
SLOFF3.01N/A
N/A
Solstad Farstad ASA
TMRAY12.85-0.06
-0.50%
Tomra Systems A/S/A
HLMAF47.77-0.36
-0.75%
Halma PLC

BNXTF and Stocks

Correlation & Price change

A.I.dvisor tells us that BNXTF and TAK have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BNXTF and TAK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNXTF
1D Price
Change %
BNXTF100%
N/A
TAK - BNXTF
32%
Poorly correlated
-0.34%
SNOA - BNXTF
29%
Poorly correlated
+0.62%
SDZXF - BNXTF
29%
Poorly correlated
N/A
ALVO - BNXTF
13%
Poorly correlated
-2.07%
ESAIY - BNXTF
11%
Poorly correlated
-1.84%
More

Groups containing BNXTF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNXTF
1D Price
Change %
BNXTF100%
N/A
Pharmaceuticals
category (380 stocks)
5%
Poorly correlated
-0.30%
Pharmaceuticals: Generic
category (214 stocks)
3%
Poorly correlated
-0.59%